| Financial Year |
March 31 2023 |
| Monetary Funds |
487,334,629.17 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
50,390,000.00 |
| Accounts Receivable |
368,143,969.37 |
| Advances to Suppliers |
56,226,564.51 |
| Other Receivables |
20,152,254.01 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
766,028,473.85 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
20,341,431.52 |
| Total Current Assets |
1,768,617,322.43 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
3,539,664.33 |
| Investment Properties |
-- |
| Fixed Assetes |
1,537,203,901.33 |
| Under-construction Projects |
65,358,680.88 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
196,865,680.97 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
3,894,672.85 |
| Other Non-Current Assets |
37,784,581.94 |
| Sub-Total of Non-Current Assets |
1,917,041,544.37 |
| Total Assets |
3,685,658,866.80 |
| Short-Term Loans |
977,750,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
320,800,000.00 |
| Accounts Payable |
484,376,972.02 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
197,352.00 |
| Taxes Payable |
3,004,695.30 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
88,836,432.46 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
263,378,994.94 |
| Other Current Liabilities |
3,044,799.91 |
| Sub-Total of Current Liabilities |
2,178,804,925.49 |
| Long-term Loans |
236,823,117.25 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
959,701.29 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
237,986,079.92 |
| Total Liabilities |
2,416,791,005.41 |
| Paid-In Capital(Or Share Stock) |
629,819,662.00 |
| Capital Surplus |
1,041,739,066.51 |
| Surplus Reserve |
7,928,393.01 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-321,044,528.84 |
| Minority Stockholder's Interest |
4,840,846.40 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,264,027,014.99 |
| Owner's Equity（Stockholder's Equity） |
1,268,867,861.39 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,685,658,866.80 |
